Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients
Clinical trial NCT05078866 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05078866
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-10
- Primary completion
- 2025-04-16
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.